Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025

Tremelimumab Plus Durvalumab in Advanced Hepatocellular Carcinoma Treatment: A Pharmacovigilance Comparative Analysis Between Eudravigilance and HIMALAYA Study

Eleonora Castellana, Patricia Madalina Budau, Maria Rachele Chiappetta

Hospital Pharmacy

Open access

Research article

First published 2026

Sequential or upfront triple combination with durvalumab,tremelimumab,and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)

Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma

Weiting Liao, Huiqiong Xu, David Hutton [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab,in combination with chemotherapy,in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11,KEAP1,or KRAS : the TRITON study

Ferdinandos Skoulidis, Hossein Borghaei, Edward B. Garon [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2022-07

A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer

Nancy Y. Lee, Nadeem Riaz, Vanessa Wu [...]

Thyroid®

Retricted access

Case report

First published 2025

Veno-arterial extracorporeal membrane oxygenation support for cardiogenic shock secondary to immune checkpoint inhibitors

Quynh Nguyen, Hossein Shayan

Perfusion

Open access

Review article

First published 2023

Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis

Hiromi Matsumoto, Kohei Somekawa, Nobuyuki Horita [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2020

Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma

Xinlun Dai, Shupeng Wang, Chunyuan Niu [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2020

Comparative risk of serious and fatal treatment-related adverse events caused by 19 immune checkpoint inhibitors used in cancer treatment: a network meta-analysis

Tingting Liu, Bo Jin, Jun Chen [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2018

Durvalumab in NSCLC: latest evidence and clinical potential

Nerea Muñoz-Unceta, Isabel Burgueño, Elizabeth Jiménez [...]

Therapeutic Advances in Medical Oncology

Search results